title: Spindle cell sarcoma of the kidney with ganglionic elements (malignant ectomesenchymoma) associated with chromosomal abnormalities and a review of the literature.
abstract: OBJECTIVE
  Malignant ectomesenchymomas are tumors that exhibit both mesenchymal and neuroectodermal elements (1). We report a case thought to represent a malignant ectomesenchymoma arising in the kidney with cytogenetic abnormalities that may provide insight into the biologic basis for this unusual tumor.
  
  
  METHODS
  We discuss the clinical features, histopathologic findings, cytogenetics, treatment, and outcome of a child with a malignant ectomesenchymoma arising in the kidney.
  
  
  RESULTS
  An asymptomatic 16-month-old boy had a large abdominal mass. The resected tumor contained sheets of spindled cells that expressed mesenchymal markers and cartilaginous differentiation, interspersed with clusters of ganglion cells that expressed neural markers. No blastemal or epithelial elements were demonstrated. Cytogenetic analysis of the tumor revealed a hyperdiploid count with multiple numerical and structural abnormalities, including a translocation between chromosomes 12 and 15. In addition to the surgical resection, the patient was successfully treated with adjuvant chemotherapy and local radiation therapy.
  
  
  CONCLUSIONS
  This is the first report of which we are aware of an ectomesenchymoma arising within the kidney. A subset of malignant ectomesenchymomas may be related to the Ewing's family of tumors (EFTs) (2), but this case did not exhibit cytogenetic features consistent with EFT. Thus, the malignant ectomesenchymoma phenotype probably represents a heterogeneous group of tumors with different genotypes and origins. Cytogenetic analysis may be instrumental in determining the appropriate therapeutic approach when faced with such a neoplasm. The outcomes of 12 other children with ectomesenchymoma are reviewed.
authors.affiliation: Department of Pediatrics, University of Utah/Primary Childrens Medical Center, Salt Lake City 84113, USA.
authors.forename: R E
authors.initials: RE
authors.lastname: Goldsby
authors.forename: C S
authors.initials: CS
authors.lastname: Bruggers
authors.forename: A R
authors.initials: AR
authors.lastname: Brothman
authors.forename: P H
authors.initials: PH
authors.lastname: Sorensen
authors.forename: J B
authors.initials: JB
authors.lastname: Beckwith
authors.forename: T J
authors.initials: TJ
authors.lastname: Pysher
mesh_terms: D002675:Child, Preschool; D002869:Chromosome Aberrations; D003131:Combined Modality Therapy; D005724:Ganglia / Q000473:pathology*; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D008297:Male; D008637:Mesenchymoma / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D012509:Sarcoma / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D016896:Treatment Outcome